...
首页> 外文期刊>World journal of gastroenterology : >Quantification of pancreatic exocrine function of chronic pancreatitis with secretin-enhanced MRCP
【24h】

Quantification of pancreatic exocrine function of chronic pancreatitis with secretin-enhanced MRCP

机译:用促胰液素增强的MRCP定量分析慢性胰腺炎的胰腺外分泌功能

获取原文
获取原文并翻译 | 示例

摘要

AIM: To obtain reference values for pancreatic flow output rate (PFR) and peak time (PT) in healthy volunteers and chronic pancreatitis (CP); to correlate quantification of secretin enhanced magnetic resonance cholangiopancreatography (SMRCP) of pancreatic fluid output following secretin with fecal elastase-1 (FE-1) tests. METHODS: The present study includes 53 subjects comprised of 17 healthy individuals and 36 patients with CP from April 2011 to January 2013. The 36 patients with CP were divided into three groups of mild CP (n = 14), moderate CP (n = 19) and advanced CP (n = 3) by M-ANNHEIM classification for CP. Fifty-three cases underwent FE-1 test and magnetic resonance imaging using 3.0 T-device (Signa EXCITE, GE Healthcare). Coronal T2-weighted single-shot turbo spin-echo, spiratory triggered, covering the papillae, duodenum and small bowel. MRCP was performed with a heavily T2-weighted fat-suppressed long TE HASTE sequence (thick slab 2D MRCP sequence), repeated every 2 min up to 11 min after 0.1 mL/kg secretin injection (Secrelux, Sanochemia?, Germany). FE-1 test used sandwich enzyme-linked immunosorbent assay (ELISA) test (ScheBo. Tech?, Germany). RESULTS: A good linear correlation showed between the calculated volume and the actual volume by Phantom experiments. Fifty-three paired Quantification of secretin enhanced magnetic resonance cholangiopancreatography (MRCPQ) and FE-1 data sets were analyzed. The mean FE-1 of 53 cases was 525.41 ± 94.44 μg/g for 17 healthy volunteers, 464.95 ± 136.13 μg/g for mild CP, 301.55 ± 181.55 μg/g for moderate CP, 229.30 ± 146.60 μg/g for advanced CP. Also, there was statistically significant difference in FE-1 (P = 0.0001) between health and CP. The mean values of PFR and PT were 8.18 ± 1.11 mL/min, 5.76 ± 1.71 min for normal; 7.27 ± 2.04 mL/min, 7.71 ± 2.55 min for mild CP; 4.98 ± 2.57 mL/min, 9.10 ± 3.00 min for moderate CP; 4.13 ± 1.83 mL/min, 12.33 ± 1.55 min for advanced CP. Further, statistically significant difference in PFR (P = 0.0001) and PT (P = 0.0001) was observed between health and CP. Besides, there was correlation (r = 0.79) and consistency (K = 0.6) between MRCPQ and ELISA Test. It was related between M-ANNHEIM classification and PFR (r = 0.55), FE-1 (r = 0.57). CONCLUSION: SMRCP can provide a safe, non-invasive and efficient method to evaluate the exocrine function of the pancreas.
机译:目的:获得健康志愿者和慢性胰腺炎(CP)的胰流输出率(PFR)和峰值时间(PT)的参考值;将促胰液素分泌后胰液输出的促胰液素增强磁共振胆管胰腺成像(SMRCP)定量与粪便弹性蛋白酶1(FE-1)测试相关联。方法:本研究包括2011年4月至2013年1月的53名受试者,包括17名健康个体和36例CP患者。将36例CP患者分为三组:轻度CP(n = 14),中度CP(n = 19) )和通过CP的M-ANNHEIM分类的高级CP(n = 3)。 53例患者使用3.0 T装置(Signa EXCITE,GE Healthcare)进行了FE-1测试和磁共振成像。冠状T2加权单发涡轮自旋回波,呼吸触发,覆盖乳头,十二指肠和小肠。 MRCP用重度T2抑制脂肪的长TE HASTE序列(厚平板2D MRCP序列)进行,在注射0.1 mL / kg促胰液素后(Secrelux,Sanochemia ?,德国)每2分钟重复一次,直到11分钟。 FE-1测试使用夹心酶联免疫吸附测定(ELISA)测试(ScheBo。Tech ?,德国)。结果:通过幻影实验,计算出的体积与实际体积之间显示出良好的线性相关性。对促胰液素增强磁共振胰胆管造影术(MRCPQ)和FE-1数据集的53对定量进行了分析。 53名患者的平均FE-1为525.41±94.44μg/ g(17名健康志愿者),轻度CP的464.95±136.13μg/ g,中度CP的301.55±181.55μg/ g,晚期CP的229.30±146.60μg/ g。此外,健康与CP之间的FE-1差异有统计学意义(P = 0.0001)。 PFR和PT的平均值为8.18±1.11mL / min,正常时为5.76±1.71min。 7.27±2.04 mL / min,轻度CP为7.71±2.55 min; 4.98±2.57 mL / min,中度CP为9.10±3.00 min; 4.13±1.83 mL / min,高级CP为12.33±1.55 min。此外,在健康和CP之间观察到PFR(P = 0.0001)和PT(P = 0.0001)的统计学差异。此外,MRCPQ和ELISA测试之间存在相关性(r = 0.79)和一致性(K = 0.6)。它与M-ANNHEIM分类和PFR(r = 0.55),FE-1(r = 0.57)有关。结论:SMRCP可以提供一种安全,无创,有效的方法来评估胰腺的外分泌功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号